[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"behavior-hyperactive\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:behavior-hyperactive":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100533930",false,"NCT06232226","Attention Deficit Hyperactivity Disorder","Addictions and Attention Deficit Disorder With or Without Hyperactivity","ADA","Inclusion Criteria :\n\n* Patients aged over 18 years\n* For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago\n* For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed\n* Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)\n* For patients who can actually benefit from MPH: who have not yet started taking MPH\n* Social security affiliates\n\nExclusion Criteria :\n\n* Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible\n* Presenting difficulties in reading or writing the French language making data collection impossible\n* Unable to commit to being available for the 2 visits planned as part of the cohort\n* Under guardianship or legal protection\n* Patients who have used psychoactive substances within 12 hours prior to their visit","ALL","18 Years","99 Years",{"count":20,"type":21},80,"ESTIMATED","INTERVENTIONAL",[24],"NA","The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.",[12,27,28],"Behavior Hyperactive","Behavior Disorders",[30,31,32,33,34,35,36],"Attention Deficit Disorder with Hyperactivity","Addictive disorders","Neuropsychology","Methylphenidate","Atomoxetine","Functional impairment","Symptoms","RECRUITING","2026-04-14",{"date":40,"type":41},"2026-04-17","ACTUAL",{"date":43,"type":41},"2024-04-11",{"date":45,"type":21},"2026-12-31",{"name":47,"class":48},"Nantes University Hospital","OTHER",3,""]